...
首页> 外文期刊>The Journal of Physiology >Adenosine transporter antagonism in humans augments vasodilator responsiveness to adenosine, but not exercise, in both adenosine responders and non-responders.
【24h】

Adenosine transporter antagonism in humans augments vasodilator responsiveness to adenosine, but not exercise, in both adenosine responders and non-responders.

机译:人类对腺苷转运蛋白的拮抗作用增强了腺苷反应者和非反应者中血管扩张剂对腺苷的反应能力,但并未增强运动能力。

获取原文
获取原文并翻译 | 示例
           

摘要

' We previously demonstrated a bimodal distribution of forearm vasodilator responsiveness to adenosine (ADO) infusion in the brachial arteries of human subjects. We also demonstrated that ADO receptor antagonism blunted exercise hyperaemia during heavy rhythmic handgripping, but vasodilator responses to exogenous ADO were only blunted in ADO responders. In this study, we continued investigating the contribution of ADO to exercise hyperaemia and possible differences between responders and non-responders. We hypothesized that ADO transporter antagonism would increase vasodilatation in response to exogenous ADO in responders only, but not effect exercise-mediated vasodilation. To test this hypothesis, we compared forearm vascular conductance (FVC) during infusion of ADO to FVC during handgripping before and after infusion of dipyridamole (DIP) in 20 subjects. In ADO responders, change in FVC above baseline (ml min-1 (100 mmHg)-1) for low, medium and high doses of ADO, respectively, was 58 +/- 8, 121 +/- 22 and 184 +/- 38, and after DIP was 192 +/- 32, 238 +/- 50 and 310 +/- 79. For non-responders, these values were 23 +/- 2, 43 +/- 5 and 66 +/- 9, respectively, before DIP (P<0.01 versus responders). Contrary to our hypothesis, these values were increased by DIP in non-responders (P<0.001) and therefore not different from responders (P>0.20). We found that ADO transporter blockade had no effect on exercise hyperaemia in either subgroup. We conclude that there may be increased ADO transporter activity in non-responders resulting in reduced ADO-mediated vasodilatation. The failure of DIP to augment exercise hyperemia under these conditions suggests that ADO concentrations may not rise enough during rhythmic handgripping to have a major impact on these responses.
机译:'我们先前证明了在人类受试者的肱动脉中,前臂血管扩张剂对腺苷(ADO)输注的反应性呈双峰分布。我们还证明了在剧烈的节律性抓握过程中,ADO受体拮抗作用使运动性充血减弱,但对外源性ADO的血管舒张反应仅在ADO响应者中减弱。在这项研究中,我们继续研究ADO对运动性充血的贡献以及应答者和非应答者之间的可能差异。我们假设ADO转运蛋白拮抗作用只会增加反应者对外源ADO的反应而增加的血管舒张作用,而不影响运动介导的血管舒张作用。为了验证这一假设,我们比较了20名受试者在输注双嘧达莫(DIP)之前和之后的手握过程中,将ADO输注期间的前臂血管传导率(FVC)与FVC进行了比较。在ADO应答者中,低,中和高剂量ADO的FVC高于基线(ml min-1(100 mmHg)-1)的变化分别为58 +/- 8、121 +/- 22和184 +/- 38,并且DIP之后为192 +/- 32、238 +/- 50和310 +/-79。对于无响应者,这些值为23 +/- 2、43 +/- 5和66 +/- 9。分别在DIP之前(P <0.01与应答者相比)。与我们的假设相反,DIP在无反应者中增加了这些值(P <0.001),因此与有反应者没有区别(P> 0.20)。我们发现,ADO转运蛋白阻滞剂对这两个亚组的运动性充血均无影响。我们得出的结论是,无应答者中ADO转运蛋白活性可能增加,导致ADO介导的血管舒张减少。在这种情况下,DIP未能增强运动性充血,这说明在有节奏的抓握过程中ADO的浓度可能升高不足,从而对这些反应没有重大影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号